The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.

The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.

A study, in which Vall d'Hebron has participated, has analysed all the interventions of this type carried out between 2006 and 2020.

The project evaluates the feasibility of implementing LOLA, an AI-based virtual medical assistant with conversational technology that provides personalized tracking to patients suffering from heart failure.

La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.

Júlia Baguña, Andrea Guala i Roberto Orsenigo han rebut una dels 105 ajuts concedits en el marc del programa INPhINIT i les 40 del programa Junior Leader.

The call will fund a project on the impact of the Low Emission Zone on the incidence of arrhythmias and another to stop liver disease related to alcohol consumption.

The study analyzes the scientific evidence on the harmful effect of environmental pollution and heavy metals on cardiovascular health and summarizes the strategies for its prevention and treatment.

Els estudis avançaran en els camps de les malalties digestives, el VIH, la fatiga crònica, les patologies cardíaques, l’hepatitis, la diabetis i l’oftalmologia.

The Interuniversity Research led by the NeuroPhar laboratory of the UPF has discovered that modulating the endocannabinoid system considerably improves some of the effects of the pathology.

El projecte pretén oferir un tractament precoç i localitzat en el moment de la teràpia de reperfusió per reduir significativament el dany del teixit i minimitzar l'aparició de complicacions cardíaques en el futur.

Researchers have presented advances in the field of myocardial infarction, non-compaction cardiomyopathy and genetic aortic pathology, in addition to hosting a meeting between international experts on vascular aging.

Researchers at Vall d'Hebron have established a simple algorithm of recommendations for taking the arterial pulse, a rapid and non-invasive method for identifying patients with atrial fibrillation, a type of arrhythmia that increases the risk of stroke.

The knowledge of these mechanisms will help to develop pharmacological strategies to prevent heart failure associated with aging.

Les malalties minoritàries són greus, poc freqüents i afecten 5 de cada 10.000 persones. N'hi ha més de 7.000, un 80% de les quals són d'origen genètic. Generalment impliquen diversos òrgans i afecten les capacitats físiques, les habilitats mentals i les qualitats sensorials i de comportament de les persones afectades.

The objective of the Tartaglia project will be to train mathematical models to support decision making and contribute to personalized and precision medicine.

Today, 30 November, the main research lines in which both institutions will be working together are revealed.

The study shows that not only excess but also iron deficiency can have detrimental effects in acute myocardial ischemia.